Cargando…
Integrating conventional and antibody-based targeted anticancer treatment into immunotherapy
In advanced cancer, current conventional therapies or immunotherapies cannot eradicate all tumor cells for most patients. Integration of these two treatments for synergistic effects could eradicate more tumor cells and increase overall survival rates. But proper integration is a challenge, partly du...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5243926/ https://www.ncbi.nlm.nih.gov/pubmed/27425593 http://dx.doi.org/10.1038/onc.2016.231 |